Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By stimulating these receptors, Retatrutide reduces hunger pangs, {promotesglucose regulation, and ultimately contributes to significant reduction in body mas